- Filed
- May 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 25, 2025 | 123M sh |
| Cash And Equivalents | Q1 2025 · Feb 2, 2025 | $1.21B |
| Cash And Equivalents | Q1 2025 · Apr 28, 2024 | $1.25B |
| Current Liabilities | Q1 2025 · Feb 2, 2025 | $1.91B |
| Current Liabilities restated | Q1 2025 · Apr 28, 2024 | $1.72B |
| Total Liabilities | Q1 2025 · Feb 2, 2025 | $3.16B |
| Total Liabilities restated | Q1 2025 · Apr 28, 2024 | $2.95B |
| Current Assets | Q1 2025 · Feb 2, 2025 | $2.75B |
| Current Assets restated | Q1 2025 · Apr 28, 2024 | $2.67B |
| Total Assets | Q1 2025 · Feb 2, 2025 | $5.3B |
| Total Assets restated | Q1 2025 · Apr 28, 2024 | $5.15B |
| Shares Diluted restated | Q1 2025 · Apr 28, 2024 | 130.63M sh |
| Stock Repurchased | Q1 2025 · Apr 28, 2024 | $43.78M |
| Dividends Paid | Q1 2025 · Apr 28, 2024 | $62.86M |
| Capex | Q1 2025 · Apr 28, 2024 | $39.51M |
| Operating Cash Flow | Q1 2025 · Apr 28, 2024 | $226.79M |
| Stockholders Equity restated | Q1 2025 · Apr 28, 2024 | $2.2B |
| Stockholders Equity | Q1 2025 · Jan 28, 2024 | $2.13B |
| Eps Diluted restated | Q1 2025 · Apr 28, 2024 | $1.99 |
| Eps Basic restated | Q1 2025 · Apr 28, 2024 | $2.03 |
| Sga Expense restated | Q1 2025 · Apr 28, 2024 | $478.06M |
| Net Income restated | Q1 2025 · Apr 28, 2024 | $260.42M |
| Operating Income restated | Q1 2025 · Apr 28, 2024 | $317.11M |
| Gross Profit restated | Q1 2025 · Apr 28, 2024 | $795.17M |
| Revenue | Q1 2025 · Apr 28, 2024 | $1.66B |